Tirzepatide has emerged as a innovative treatment option for individuals seeking effective reduction of body mass. As a dual-acting medication, it simultaneously targets both the hormones insulin and glucagon, leading to enhanced metabolic function associated with obesity. Clinical trials have demonstrated impressive results with tirzepatide, showi